Expand ATHE Menu
ATHE MENU

ATHE Latest Press Releases

-- November 12, 2025 --

Alterity Therapeutics to Present at the Bell Potter Healthcare Virtual Conference Globe Newswire 7:25 AM

-- November 10, 2025 --

Alterity Therapeutics Presents Promising Impact of ATH434 on Orthostatic Hypotension and Disease Progression in MSA at the 36th International Symposium on the Autonomic Nervous System Globe Newswire 7:25 AM

-- October 31, 2025 --

Alterity Therapeutics: Appendix 4C - Q1 FY26 Quarterly Cash Flow Report Globe Newswire 7:25 AM

-- October 9, 2025 --

Alterity Therapeutics Presents Positive Data from ATH434 Phase 2 Trial at the 2025 International Congress of Parkinson's Disease and Movement Disorders Globe Newswire 7:25 AM

-- October 2, 2025 --

Alterity Therapeutics to Deliver Multiple Presentations at the 2025 International Congress of Parkinson's Disease and Movement Disorders Globe Newswire 7:35 AM

-- September 15, 2025 --

Alterity Therapeutics Presents ATH434-201 Phase 2 Data at the American Neurological Association Annual Meeting Globe Newswire 7:25 AM

-- September 8, 2025 --

Alterity Therapeutics Raises A$20.0 million in Strategic Placement Globe Newswire 7:35 AM

-- September 2, 2025 --

Alterity Therapeutics to Present at the Biotech Showcase Globe Newswire 7:25 AM

-- July 30, 2025 --

Appendix 4C - Q4 FY25 Quarterly Cash Flow Report Globe Newswire 7:25 AM

-- July 28, 2025 --

Alterity Therapeutics Reports Positive Topline Data from Open-Label Phase 2 Clinical Trial of ATH434 in Multiple System Atrophy Globe Newswire 7:25 AM

-- July 24, 2025 --

Alterity Therapeutics Announces Publication on Novel MRI Endpoint from the bioMUSE Natural History Study Globe Newswire 7:25 AM
Market Data Delayed 15 Minutes